97
Participants
Start Date
January 2, 2019
Primary Completion Date
October 11, 2023
Study Completion Date
March 31, 2024
Onsite treatment
Participants will see a buprenorphine treatment provider who will assess for clinical criteria for opioid use disorder and write a prescription for buprenorphine treatment, which will be filled in a community pharmacy.
Enhanced referral
Participants will receive an expedited appointment at a community health center for evaluation for buprenorphine treatment
Buprenorphine
all participants will receive buprenorphine
Washington Heights CORNER Project, New York
New York Harm Reduction Educators, New York
BOOM!Health Harm Reduction Center, The Bronx
National Institute on Drug Abuse (NIDA)
NIH
Montefiore Medical Center
OTHER